1.64Delayed Data As of 9:53am ET | -0.038 / -2.26%Today’s Change | 1.62 Today|||52-Week Range 4.14 | -28.30% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $8.7M |
Company Description
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program, focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.
Employees

Shareholders
Mutual fund holders | 0.66% |
Other institutional | 0.22% |
Individual stakeholders | -- |
Top Executives
Joshua Levine | Chief Executive Officer |
David Kestenbaum | Chief Financial Officer |
Daphna Paran | Medical Director |